← Eichor
Study identifier: NCT06825520 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics

Condition: Tics · Tourette Disorder · Tourette Syndrome in Children  ·  Sponsor: University of Utah

PhaseNA
Planned participants6
Who can joinAll sexes, 8 Years to 17 Years
Healthy volunteersNo

About this study

The primary aim of this study is to learn more about premonitory urges (PU) when using Habit Reversal Training (HRT) to treat tics. The main focus of this study is to investigate if and when PU change during tic treatment sessions and between tic treatment sessions. Participants will: * Attend 5 study visits (approximately 1 to 1.5 hours each) for an intake, habit reversal training for 3 separate tics, and a post assessment * Attend 5 practice sessions (approximately 30 minutes each) over a week for 3 weeks (total 15 practice sessions) * Study visits and practice sessions will take place in person and online via secure videoconference

This description comes directly from the study's public registry record.

Talk to the study team

Emily I Braley, MS  ·  801-585-7114  ·  theticlab@utah.edu

Michael Himle, PhD  ·  801-581-7529  ·  michael.himle@utah.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of UtahSalt Lake City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06825520